Yes, a Japan DMAH (Designated Marketing Authorization Holder) must conduct quality testing before product release to ensure compliance with regulatory standards. This ensures product safety, efficacy, and quality, aligning with Japan’s Pharmaceutical and Medical Device Act. Rigorous testing helps prevent market entry of substandard products, safeguarding public health and maintaining trust.
